[Ferroptosis inducer Erastin inhibits proliferation of liver cancer cells <i>in vitro</i> by downregulating ACSL4].

ACSL4 level is significantly overexpressed in liver cancer. Erastin increases MDA contents and down-regulates ACSL4 expression, thereby promoting ferroptosis and inhibiting proliferation of liver cancer cells, and these effects can be reversed by Fer-1.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-11-20
DOI
https://doi.org/10.12122/j.issn.1673-4254.2024.11.09
Citations
1
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Ferroptosis inducer Erastin inhibits proliferation of liver cancer cells in vitro by downregulating ACSL4].

Zihui Zhou, Yi Tu, Sing‐Han Huang, Pan Zhao et al.
1 citations
PubMed
Ferroptosis and cancer prognosis
article

[Ferroptosis inducer Erastin inhibits proliferation of liver cancer cells in vitro by downregulating ACSL4].

Zihui Zhou, Yi Tu, Sing‐Han Huang, Pan Zhao, Liang Yu, Jian Tu
article en
1 citations

Abstract

ACSL4 level is significantly overexpressed in liver cancer. Erastin increases MDA contents and down-regulates ACSL4 expression, thereby promoting ferroptosis and inhibiting proliferation of liver cancer cells, and these effects can be reversed by Fer-1.

PubMedVol. 44(11)
Guilin Medical University (CN)
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.